Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Semantic Scholar uses AI to extract papers important to this topic.
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171… Expand The spinal cord is the first relay site in the transmission of nociceptive information from the periphery to the brain. Sensory… Expand Multiple sources of evidence support a role for diminished dopaminergic neurotransmission in major depression. The physiological… Expand BACKGROUND
This is an updated version of the original Cochrane review published in Issue 3, 2005 of The Cochrane Library. For… Expand New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned CNS receptors and their… Expand CONTEXT
A neonatal behavioral syndrome linked to in utero serotonin reuptake inhibitor (SRI) exposure during the last trimester… Expand Abstract The class of serotonin and norepinephrine reuptake inhibitors (SNRIs) now comprises three medications: venlafaxine… Expand OBJECTIVE
Antidepressants that inhibit the reuptake of serotonin (SSRIs) or norepinephrine (SNRIs) are effective in the treatment… Expand 5-Hydroxytryptamine (serotonin) (5-HT) and norepinephrine (NE) are implicated in modulating descending inhibitory pain pathways… Expand Depressive disorders, including major depression and dysthymia, are serious disabling illnesses. Approximately one in five… Expand